Place of phytotherapy in the treatment of acute infections of upper respiratory tract and upper gastrointestinal tract

2018 ◽  
Vol 72 (4) ◽  
pp. 42-50 ◽  
Author(s):  
Wioletta Pietruszewska ◽  
Magda Barańska ◽  
Jakub Wielgat

Acute infections of the upper respiratory tract and upper gastrointestinal tract (mouth and throat) are still the most common reason for reporting to the general practitioner or ENT specialist. Despite the fact that the most common causative agent of these diseases are virurs, antibiotics are still flavored in about 60-80% of patients who report to the doctor. In consensus such as EPOS, WHO reports and other local / national reports, there is a need to limit antibacterial treatment for symptomatic and anti-inflammatory drugs. In addition to intranasal steroids and mucocutaneous decongestants, supplementary treatment should be considered which resolves persistent symptoms. Plant preparations are used here. The growing role of rational phytotherapy is emphasized, especially due to the most frequent etiological factor of these infections, i.e. viruses. Modern phytotherapy is part of pharmacology, and all preparations based on plants meet the standards for medicines and are subject to standard registration procedures. The article discusses the use and mechanism of action of selected herbs, among others: sorrel, elderberry, yarrow and horsetail in the treatment of upper respiratory tract infections and upper gastrointestinal tract. The phytotherapy show good efficacy and tolerance, and can be used both in children and adults in recurrent infections of the upper respiratory tract. It is worth paying attention to the combined preparations, the components of which have the effect confirmed by randomized trials and long-term registration for use in treatment, both during the first signs of cold and its further duration, and supportive in chronic inflammation especially of the paranasal sinuses.

2013 ◽  
Vol 62 (4) ◽  
pp. 385-390 ◽  
Author(s):  
IZABELA KORONA-GLOWNIAK ◽  
ARTUR NIEDZIELSKI ◽  
ANNA MALM ◽  
GRAŻYNA NIEDZIELSKA

We investigated children aged 2-5, who had gone adenoidectomy for recurrent and/or persistent symptoms of upper respiratory tract infections for prevalence of pneumococci in adenoid tissue. Serotypes and antibiotic resistance patterns of the isolated pneumococci were determined and also risk factors of pneumococcal colonization were defined. S. pneumoniae colonization in adenoids was found in 62 (60.2%) children. Serotypes belonged to 10-valent and 13-valent pneumococcal conjugated vaccines (PCVs) constituted 56.1% and 68.2% of the isolates, respectively. Decreased susceptibility to penicillin was found in 45.5% of isolates; pneumococci were resistant to cotrimoxazole (62.1%), tetracycline (43.9%), erythromycin (54.5%), clindamycin (54.5%) and chloramphenicol (31.8%). Multidrug resistant S. pneumoniae comprised 57.6% of the isolates. Antibiotic resistant pneumococci were mostly distributed among serotypes belonged to 10-valent and 13-valent PCVs. Good vaccine coverage among the isolated pneumococci confirmed that the introduction of PCVs in the national immunization programme may reduce the pool of resistant and multidrug resistant pneumococci in a community.


Sign in / Sign up

Export Citation Format

Share Document